Silicon Laboratories (NASDAQ:SLAB) Rating Lowered to “Sell” at StockNews.com

Silicon Laboratories (NASDAQ:SLAB) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Thursday.

SLAB has been the subject of a number of other research reports. Barclays boosted their target price on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, January 17th. Stifel Nicolaus boosted their price objective on Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research note on Monday, January 6th. Needham & Company LLC restated a “buy” rating and issued a $150.00 target price on shares of Silicon Laboratories in a research report on Wednesday, March 12th. Benchmark reaffirmed a “buy” rating and issued a $160.00 price target on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Finally, KeyCorp increased their price objective on Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $136.20.

Silicon Laboratories Price Performance

SLAB stock traded down $1.80 during mid-day trading on Thursday, reaching $119.57. 299,434 shares of the company’s stock were exchanged, compared to its average volume of 305,552. Silicon Laboratories has a 12-month low of $94.00 and a 12-month high of $160.00. The stock’s 50 day moving average is $137.08 and its 200 day moving average is $123.48. The company has a market cap of $3.88 billion, a price-to-earnings ratio of -20.13 and a beta of 1.15.

Silicon Laboratories (NASDAQ:SLAB) last announced its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The firm had revenue of $166.25 million for the quarter, compared to analyst estimates of $166.09 million. During the same quarter last year, the firm posted ($1.19) EPS. The business’s revenue was up 91.4% on a year-over-year basis. On average, research analysts forecast that Silicon Laboratories will post -0.97 earnings per share for the current fiscal year.

Insider Activity

In related news, Director William G. Bock sold 2,000 shares of the business’s stock in a transaction on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the sale, the director now owns 32,115 shares in the company, valued at approximately $4,520,828.55. The trade was a 5.86 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the firm’s stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the transaction, the director now owns 400,567 shares of the company’s stock, valued at $59,684,483. This trade represents a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 5,360 shares of company stock valued at $782,610. Company insiders own 1.72% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Coldstream Capital Management Inc. boosted its stake in shares of Silicon Laboratories by 2.8% in the 4th quarter. Coldstream Capital Management Inc. now owns 2,473 shares of the semiconductor company’s stock valued at $307,000 after buying an additional 68 shares during the period. Jones Financial Companies Lllp raised its holdings in Silicon Laboratories by 44.5% in the fourth quarter. Jones Financial Companies Lllp now owns 224 shares of the semiconductor company’s stock valued at $28,000 after acquiring an additional 69 shares in the last quarter. Pacer Advisors Inc. lifted its stake in Silicon Laboratories by 1.8% in the fourth quarter. Pacer Advisors Inc. now owns 4,839 shares of the semiconductor company’s stock worth $601,000 after acquiring an additional 87 shares during the last quarter. Louisiana State Employees Retirement System grew its holdings in Silicon Laboratories by 1.1% during the 4th quarter. Louisiana State Employees Retirement System now owns 9,000 shares of the semiconductor company’s stock worth $1,118,000 after acquiring an additional 100 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. increased its position in shares of Silicon Laboratories by 1.4% in the 4th quarter. Oppenheimer Asset Management Inc. now owns 7,169 shares of the semiconductor company’s stock valued at $891,000 after purchasing an additional 102 shares during the last quarter.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.